LIN28B is an RNA-binding protein that functions as a suppressor of microRNA biogenesis, primarily by inhibiting let-7 maturation 1. It binds primary let-7 transcripts and sequesters them in the nucleolus, preventing their processing by the microprocessor complex 1. This let-7 repression is essential for maintaining pluripotency in embryonic stem cells and regulating development 2. Beyond let-7 regulation, LIN28B exhibits diverse biological functions. It plays critical roles in pubertal development and reproductive timing 3, with LIN28B being the predominant paralog in human placenta where it promotes trophoblast differentiation and invasion 4. Mechanistically, LIN28B can activate PI3K/AKT signaling pathways in cancer contexts 5 and regulates endothelial barrier function through ALDH2-mediated modulation of ELK3 mRNA stability 6. Clinically, LIN28B is frequently overexpressed in multiple cancers, including neuroblastoma (~15% of pediatric cancer mortality) and colorectal cancer (30% of cases) 75. This overexpression contributes to hallmarks of cancer including proliferation, metastasis, metabolic reprogramming, and immune evasion 28. Reduced LIN28B expression associates with preeclampsia, suggesting loss-of-function pathology in this condition 4.